{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Fa4b5a1f4-53e3-450a-9a6b-9fcbb868e59b","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"An interview with Angeles Alvarez Secord, MD, MHSc \u2014 Management of Ovarian and Endometrial Cancer\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/a4b5a1f4-53e3-450a-9a6b-9fcbb868e59b\"></iframe>","title":"An interview with Angeles Alvarez Secord, MD, MHSc \u2014 Management of Ovarian and Endometrial Cancer","description":"\n        <p>Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers, moderated by Dr Neil Love. Produced by Research To Practice. </p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/OncologyTodayASCOOvarianEndo24\" rel=\"nofollow\">here</a>. </p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/a21143d7-27f1-4acf-8fb0-5b7dd09ed0af/cover.jpg"}